Bcl-2–associated athanogene 3 protects the heart from ischemia/reperfusion injury

Feifei Su(Temple University), Arthur M. Feldman(Johns Hopkins University)
JCI Insight
November 16, 2016
10.1172/jci.insight.90931
Cited by 48

Related Papers

Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
|Circulation|2004|1.2k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
Cardiac S100A1 Protein Levels Determine Contractile Performance and Propensity Toward Heart Failure After Myocardial Infarction
|Circulation|2006|145
Arginine Vasopressin Enhances Cell Survival via a G Protein–Coupled Receptor Kinase 2/β-Arrestin1/Extracellular-Regulated Kinase 1/2–Dependent Pathway in H9c2 Cells
|Molecular Pharmacology|2013|37